alprazolam has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (53.85) | 18.7374 |
1990's | 12 (46.15) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adam, K; Oswald, I | 1 |
Bernabeu, F; Braquet, P; Gómez-Garre, D; López-Farré, A; López-Novoa, JM; Perez-Rodrigo, P; Ramón y Cajal, S | 1 |
Ferguson-Chanowitz, KM; Kaplan, JB; Katocs, AS; Kerwar, SS; Oronsky, AL; Pickett, WC; Sass, PM | 1 |
Fenton, JW; Kaplan, JE; Krasodomski, JA; Moon, DG; Morton, KD; van der Zee, H | 1 |
Bernabeu, F; Braquet, P; Gómez-Garre, D; López-Farré, A; López-Novoa, JM; Ramon y Cajal, S | 1 |
O'Neill, C; Spinks, NR | 1 |
Bernardini, R; Brucke, T; Calogero, AE; Chrousos, GP; Ehrlich, YH; Gold, PW | 1 |
Cunningham, F; Greaves, MW; Kobza-Black, A; Ormerod, AD | 1 |
Bittner, C; Lambrecht, G; Parnham, MJ | 1 |
Bazan, HE; Bazan, NG; Reddy, ST; Woodland, JM | 1 |
Hayashi, M; Kimura, J; Nomura, H; Oh-Ishi, S; Tsushima, S | 1 |
Darius, H; Lefer, AM; Smith, JB | 1 |
Chang, SW; Henson, PM; McMurtry, IF; Pfeffer, KD; Voelkel, NF; Worthen, SG | 1 |
Darius, H; Lefer, AM; Lefer, DJ; Smith, JB | 1 |
Cagen, LM; Chesney, CM; Pifer, DD | 1 |
Casals-Stenzel, J | 1 |
Cox, CP; Wood, KL | 1 |
Baer, PG; Cagen, LM | 1 |
Ehrlich, YH; Kornecki, E; Lenox, RH | 1 |
Chandel, B; Deshpande, Y; Kaminski, DL; Longo, WE; Niehoff, M; Polities, G; Robinson, S; Vernava, AM | 1 |
Greenlees, C; Medhurst, AD; Parsons, AA; Smith, SJ | 1 |
Gonzalez-Sarmiento, R; López-Novoa, JM; Rodriguez-Barbero, A; Rodriguez-Lopez, AM | 1 |
Feuerstein, G; Friedman, E; Wang, HY; Yue, TL | 1 |
Deshpande, YG; Feinstein, WK; Kaminski, DL | 1 |
Gardner, CR; Laskin, DL; Laskin, JD | 1 |
Sharma, A; Singh, M; Singh, N | 1 |
26 other study(ies) available for alprazolam and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Article | Year |
---|---|
Possible mechanism for adverse reactions to triazolam.
Topics: Alprazolam; Anxiety; Humans; Platelet Activating Factor; Receptors, GABA-A; Substance Withdrawal Syndrome; Triazolam | 1991 |
Platelet-activating factor mediates glycerol-induced acute renal failure in rats.
Topics: Acute Kidney Injury; Alprazolam; Animals; Disease Models, Animal; Diterpenes; Ginkgolides; Glomerular Filtration Rate; Glycerol; Kidney; Kidney Failure, Chronic; Lactones; Male; Plant Extracts; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1990 |
Platelet-activating factor or a platelet-activating factor antagonist decreases tumor necrosis factor-alpha in the plasma of mice treated with endotoxin.
Topics: Alprazolam; Animals; Cell Line; Endotoxins; Enzyme-Linked Immunosorbent Assay; Indomethacin; Kidney; Lipopolysaccharides; Liver; Mice; Mice, Inbred BALB C; Platelet Activating Factor; RNA, Messenger; Shock, Septic; Tumor Necrosis Factor-alpha | 1990 |
Platelet activating factor and sheep platelets: a sensitive new bioassay.
Topics: Adenosine Diphosphate; Alprazolam; Animals; Azepines; Biological Assay; Blood Platelets; Cell Separation; Furans; Platelet Activating Factor; Platelet Aggregation; Serotonin; Sheep; Thrombin; Triazines; Triazoles | 1990 |
Platelet-activating factor antagonists treatment protects against postischemic acute renal failure in rats.
Topics: Acute Kidney Injury; Alprazolam; Animals; Diterpenes; Ginkgolides; Glomerular Filtration Rate; Ischemia; Kidney; Lactones; Male; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1990 |
Antagonists of embryo-derived platelet-activating factor prevent implantation of mouse embryos.
Topics: Alprazolam; Animals; Capillary Permeability; Embryo Implantation; Epoprostenol; Estradiol; Female; Iloprost; Mice; Platelet Activating Factor; Progesterone; Quinolinium Compounds; Uterus | 1988 |
The alkyl-ether phospholipid platelet-activating factor is a stimulator of the hypothalamic-pituitary-adrenal axis in the rat.
Topics: Adrenocorticotropic Hormone; Alprazolam; Animals; Arachidonic Acid; Arachidonic Acids; Central Nervous System; Corticosterone; Corticotropin-Releasing Hormone; Diterpenes; Ginkgolides; Hypothalamo-Hypophyseal System; Hypothalamus; Lactones; Male; Pituitary Gland; Pituitary-Adrenal System; Platelet Activating Factor; Rats; Rats, Inbred Strains; Verapamil | 1989 |
Effects of alprazolam on platelet activating factor-induced wealing.
Topics: Adult; Alprazolam; Dermatitis, Contact; Humans; Platelet Activating Factor | 1989 |
Antagonism of platelet activating factor-induced chemiluminescence in guinea-pig peritoneal macrophages in differing states of activation.
Topics: Alprazolam; Animals; Benzofurans; Diterpenes; Furans; Ginkgolides; Guinea Pigs; In Vitro Techniques; Lactones; Lignans; Luminescent Measurements; Macrophage Activation; Macrophages; Male; Platelet Activating Factor; Thiazoles | 1989 |
The accumulation of platelet activating factor in the injured cornea may be interrelated with the synthesis of lipoxygenase products.
Topics: Alprazolam; Animals; Arachidonic Acids; Burns, Chemical; Cornea; Corneal Injuries; Diterpenes; Ginkgolides; Lactones; Lipoxygenase; Lipoxygenase Inhibitors; Luminescent Measurements; Plant Extracts; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 1987 |
Characterization of the activity of a platelet activating factor antagonist, CV-3988.
Topics: Alprazolam; Animals; Autacoids; Blood Pressure; Capillary Permeability; Dose-Response Relationship, Drug; Male; Phospholipid Ethers; Platelet Activating Factor; Rabbits; Rats; Rats, Inbred Strains; Skin; Thiazoles | 1987 |
Inhibition of the platelet activating factor mediated component of guinea pig anaphylaxis by receptor antagonists.
Topics: Alprazolam; Anaphylaxis; Animals; Benzodiazepines; Benzofurans; Benzopyrans; Diphenhydramine; Guinea Pigs; Histamine; Lignans; Male; Muscle Contraction; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; SRS-A | 1986 |
PAF antagonists: different effects on platelets, neutrophils, guinea pig ileum and PAF-induced vasodilation in isolated rat lung.
Topics: Alprazolam; Angiotensin II; Animals; Blood Platelets; Dose-Response Relationship, Drug; Guinea Pigs; Ileum; Muscle Contraction; Neutrophils; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pulmonary Artery; Pulmonary Circulation; Rabbits; Rats; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Serotonin; SRS-A; Thiazoles; Vasodilation | 1986 |
Role of platelet-activating factor-acether in mediating guinea pig anaphylaxis.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Alprazolam; Anaphylaxis; Animals; Anti-Inflammatory Agents; Benzodiazepines; Blood Pressure; Diphenhydramine; Guinea Pigs; In Vitro Techniques; Kinetics; Lung; Male; Ovalbumin; Platelet Activating Factor; Platelet Count; Pyrazoles | 1986 |
Triazolobenzodiazepines competitively inhibit the binding of platelet activating factor (PAF) to human platelets.
Topics: Alprazolam; Binding, Competitive; Blood Platelets; Diazepam; Humans; In Vitro Techniques; Kinetics; Platelet Activating Factor; Platelet Aggregation; Triazolam | 1987 |
Triazolodiazepines are potent antagonists of platelet activating factor (PAF) in vitro and in vivo.
Topics: Alprazolam; Animals; Azepines; Blood Pressure; Guinea Pigs; Humans; Hypnotics and Sedatives; In Vitro Techniques; Injections, Intravenous; Neutrophils; Platelet Activating Factor; Platelet Aggregation; Respiration; Triazolam | 1987 |
Selective antagonism of platelet-activating factor (PAF)-induced aggregation and secretion in washed rabbit platelets by CV-3988, L-652731, triazolam and alprazolam.
Topics: Alprazolam; Animals; Blood Platelets; Furans; In Vitro Techniques; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation; Rabbits; Serotonin; Thiazoles; Triazolam | 1987 |
Platelet activating factor vasoconstriction of dog kidney. Inhibition by alprazolam.
Topics: Alprazolam; Animals; Blood Pressure; Dogs; Ergolines; Female; Kidney; Male; Meclofenamic Acid; Methysergide; Platelet Activating Factor; Platelet Aggregation; Regional Blood Flow; Saralasin; Vascular Resistance; Vasoconstriction | 1987 |
Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines.
Topics: Adenosine Diphosphate; Alprazolam; Anti-Anxiety Agents; Arachidonic Acid; Arachidonic Acids; Benzodiazepines; Blood Platelets; Calcimycin; Chromatography, Gel; Collagen; Epinephrine; Humans; Platelet Activating Factor; Platelet Aggregation; Thrombin; Triazolam | 1984 |
Effect of platelet-activating factor and its antagonists on colonic dysmotility and tissue levels of colonic neuropeptides.
Topics: Alprazolam; Animals; Azepines; Colitis; Colon; Gastrointestinal Motility; In Vitro Techniques; Iodine Radioisotopes; Neuropeptides; Platelet Activating Factor; Rabbits; Substance P; Triazoles; Vasoactive Intestinal Peptide | 1994 |
Nitric oxide synthase inhibitors 7- and 6-nitroindazole relax smooth muscle in vitro.
Topics: Alprazolam; Animals; Azepines; Colitis; Colon; Gastrointestinal Motility; In Vitro Techniques; Iodine Radioisotopes; Neuropeptides; Platelet Activating Factor; Rabbits; Substance P; Triazoles; Vasoactive Intestinal Peptide | 1994 |
Gentamicin activates rat mesangial cells. A role for platelet activating factor.
Topics: Alprazolam; Animals; Base Sequence; Calcium; Cell Division; Cells, Cultured; Diterpenes; Genes, fos; Gentamicins; Ginkgolides; Glomerular Filtration Rate; Glomerular Mesangium; Lactones; Leucine; Molecular Sequence Data; Platelet Activating Factor; Rats; Rats, Wistar; RNA, Messenger | 1995 |
Platelet-activating factor: diminished acetylcholine release from rat brain slices is mediated by a Gi protein.
Topics: Acetylcholine; Alprazolam; Animals; Brain; Cerebral Cortex; GTP-Binding Proteins; Hippocampus; Norepinephrine; Platelet Activating Factor; Potassium; Rats; Serotonin; Tetrodotoxin; Triazolam; Tritium | 1994 |
The production of experimental cholecystitis by endotoxin.
Topics: Alprazolam; Animals; Cats; Cholecystitis; Gallbladder; Indomethacin; Lipopolysaccharides; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prostaglandins; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 1994 |
Platelet-activating factor-induced calcium mobilization and oxidative metabolism in hepatic macrophages and endothelial cells.
Topics: Alprazolam; Animals; Calcium; Cells, Cultured; Endothelium; Female; Kinetics; Kupffer Cells; Liver; Oxygen Consumption; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Superoxides; Tetradecanoylphorbol Acetate; Triazolam; Verapamil | 1993 |
Possible mechanism of alprazolam-induced amnesia in mice.
Topics: Alprazolam; Amnesia; Animals; Azepines; Drug Evaluation, Preclinical; Female; Flumazenil; GABA Agonists; Male; Maze Learning; Mice; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thienopyridines; Triazoles | 1998 |